Covered recipient · General Payments record
KIMBERLY A BARNHILL
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner
General Payments · PY2021–2024
$1,285.40
- Reported across 93 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $325.57 | 28 |
| Education | $84.00 | 1 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $152.63 | 18 |
| Janssen Biotech, Inc. | $100.30 | 2 |
| Takeda Pharmaceuticals U.S.A., Inc. | $41.12 | 2 |
| Phathom Pharmaceuticals, Inc. | $31.45 | 2 |
| Madrigal Pharmaceuticals | $27.99 | 2 |
| Ardelyx, Inc. | $21.88 | 1 |
| Gilead Sciences, Inc. | $20.28 | 1 |
| Merck Sharp & Dohme Corporation | $13.92 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (29)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $4.40 | 01/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106486982 | CMS |
| ABBVIE INC. | $6.00 | 01/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106486984 | CMS |
| ABBVIE INC. | $10.28 | 02/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106486986 | CMS |
| ABBVIE INC. | $17.70 | 02/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106486988 | CMS |
| ABBVIE INC. | $10.92 | 03/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106486990 | CMS |
| ABBVIE INC. | $8.60 | 04/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106486992 | CMS |
| ABBVIE INC. | $9.10 | 04/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106486994 | CMS |
| ABBVIE INC. | $16.92 | 05/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106486996 | CMS |
| ABBVIE INC. | $3.60 | 06/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106486998 | CMS |
| ABBVIE INC. | $20.25 | 06/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106487000 | CMS |
| ABBVIE INC. | $10.75 | 07/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106487002 | CMS |
| ABBVIE INC. | $4.88 | 08/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106487004 | CMS |
| ABBVIE INC. | $1.77 | 08/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106487006 | CMS |
| ABBVIE INC. | $14.47 | 09/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106487008 | CMS |
| ABBVIE INC. | $4.06 | 09/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106487010 | CMS |
| ABBVIE INC. | $3.66 | 10/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106487012 | CMS |
| ABBVIE INC. | $2.49 | 11/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106487014 | CMS |
| ABBVIE INC. | $2.78 | 12/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106487016 | CMS |
| Ardelyx, Inc. | $21.88 | 10/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146718035 | CMS |
| Gilead Sciences, Inc. | $20.28 | 09/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133648020 | CMS |
| Janssen Biotech, Inc. | $16.30 | 03/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078477439 | CMS |
| Janssen Biotech, Inc. | $84.00 | 07/11/2024 | Education | Undisputed | 01/23/2026 | 1078476293 | CMS |
| Madrigal Pharmaceuticals | $14.54 | 10/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144187271 | CMS |
| Madrigal Pharmaceuticals | $13.45 | 11/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144187273 | CMS |
| Merck Sharp & Dohme LLC | $13.92 | 06/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141632361 | CMS |
| Phathom Pharmaceuticals, Inc. | $17.50 | 04/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151147466 | CMS |
| Phathom Pharmaceuticals, Inc. | $13.95 | 11/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151147468 | CMS |
| Takeda Pharmaceuticals U.S.A., Inc. | $13.14 | 03/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1137710977 | CMS |
| Takeda Pharmaceuticals U.S.A., Inc. | $27.98 | 10/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1137710979 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.